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Introductory Thoughts 
 
 
The following research will outline the effects of psychedelics from an 
interdisciplinary approach, which is to say that I will explore the neuroscience behind 
psychedelic drugs and how it relates to creativity, as a primary focus, while examining 
the role of additional points included along the way. The goal of this research, is to gain a 
deeper understanding of psychedelics and truly decipher what it means to be under the 
influence, as the most important goal of this human existence is to achieve understanding. 
The aforementioned is a point that great minds like Albert Einstein and Humphry 
Osmond impressed on society before their death. It is a difficult and beautiful thing to 
observe the many differences, we humans feature. However, thinkers like Osmond and 
Einstein eloquently offered the ever-so-valuable point that understanding comes from the 
purposeful acknowledgment of our uniqueness as individuals and the potential for the 
role it plays. It is not in our similarities that we learn the best lessons but often our 
differences that spark the creative innovation housed in the human spirit. However, one 
must be cognitively flexible to do so.  
Aside from the academic purpose of this paper, a personal motivation for me to 
write about psychedelics stems from the fact that psilocybin (magic mushrooms), lysergic 
acid diethylamide (LSD), methylenedioxymethamphetamine (MDMA), 
tetrahydrocannabinol (marijuana or cannabis), and other psychedelic substances are 
considered taboo to talk about. Education is essential when referencing illicit drugs, and 
the only way to understand the reality of the benefits and dangers is with education; by 
removing the fear surrounding the unknown.  
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Terminology 
 
Serotonin – Neurotransmitter  
Lysergic acid diethylamide (LSD) – Synthetic compound 
Methylenedioxymethamphetamine (MDMA) – Synthetic compound 
Tetrahydrocannabinol (marijuana or cannabis) – Natural compound 
Psilocybin (magic mushrooms) – Natural compound 
Trimethoxyphenethylamine (peyote or mescaline) – Natural compound 
Dimethyltryptamine (DMT) – Natural compound 
 Ayahuasca – Natural compound 
Microdosing – Non-psychoactive doses of psychedelics 
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Psychedelics 
 
A single word wields considerable power and controversy. The term 
“psychedelic” is relatively new (a bit more than half a century) to common vernacular 
and was an adaptation to language by the psychiatrist Humphry Osmond in 1956 
(Osmond & Agel, 1981). A term that would appropriately represent psychoactive 
compounds was needed. A shift away from terminology like psychotomimetics was 
needed; this term was widely used during the 1960's, in major scientific circles, though 
perhaps not with the public. Also, terms like illusinogen, psychotaraxic, phantasticant, 
oneirogenic, or even the more common ethonogen were used in the field and were limited 
in scope and meaning (Nichols, 2016; Osmond & Agel, 1981). The term “hallucinogen,” 
also limited but more commonly known and used (even today), cast a wide net. The 
ideology behind the term pushed right into the 21st-century modern-day conversation, 
despite the misleading nature of the word — in low doses psychedelics do not produce 
hallucinations, but we will discuss dosing later (Nichols, 2016; Osmond, 1957; Osmond 
& Agel, 1981; Doblin, 2016). A close but limited term that Louis Lewin offered was 
fantastica; however, Osmond believed the term lacked the neutrality that he desired 
(Osmond & Agel, 1981).  The term hallucinogen cast a wide net, one that still expands 
over modern day conversation, despite the misleading nature of the word — in regular 
doses psychedelics do not always produce hallucinations, but we will discuss dosing later 
(Nichols, 2016, Osmond, 1957; Osmond & Agel, 1981). A close but limited term that 
Louis Lewin offered was fantastica; however, Osmond believed the term lacked the 
neutrality that he desired (Osmond, 1957; Osmond & Agel, 1981). 
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The unique qualities of the substances deserved a more appropriate description, 
one that truly embodied their function without misleading society in the way that the 
previous terms had done; Osmond (1981) claimed that the popular language conjoined 
negative associations to psychedelics within the public and private sectors, implying that 
they were psychosis-mimicking compounds, which still stands as a grossly misleading 
thought despite his efforts. In Osmond’s book, Predicting the Past, the narrative flow of 
precisely how the word came to fruition is illustrated well with the exchanges between 
him and Huxley found within the pages. Osmond received a much-anticipated response 
from Huxley which offered the term phanerothyme. The etymological foundation for 
phanerothyme comes from the Greek phaneroin, which is to reveal, paired with thumos, 
the soul (Osmond, 1957; Osmond & Agel, 1981). Although Osmond thought it an 
excellent term, he felt it would be too complicated for the lay community to grasp the 
meaning. However, Huxley's term was a great starting point for Osmond and offered 
inspiration. He grabbed for his Latin dictionary, which featured some Greek medical 
terms, and as he thumbed through its pages, he came across the Greek term psykhe, 
meaning mind, and paired it with deloun from delos, which is to reveal or make clear 
(Harper, 2018; Osmond, 1957; Osmond & Agel, 1981). Osmond hoped to join two 
concepts: the psyche and transcendence, which is the birthplace of psychedelic. In his 
response to Huxley, he quipped, "to fall in Hell or soar angelic, you will need a pinch of 
psychedelic," and this marks the very moment the term pressed to paper for the first time 
in history (Osmond & Agel, 1981). The pair initially exchanged discourse on the topic 
via mail, then in March of 1957 Osmond published “A Review of the Clinical Effects of 
Psychotomimetic Agents” for the New York Academy of Medicine, which is where he 
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publically coined the term psychedelic (Osmond, 1957). The term specifically related to 
LSD, mushrooms, and peyote (mescaline) at the time (Osmond, 1957). 
The most common definition of psychedelic, since Osmond’s time, is a compound 
that produces psychoactive effects which alter the perception of reality and cognition or 
is considered mind altering. I plan to explore the differences in the classifications of 
psychedelics, as it relates to chemical composition. A significant claim in my writing is 
that in understanding the fundamental principles of the biochemistry and cognitive 
neuroscience to gain a deeper understanding of how it all comes together to create the 
psychedelic experience, or how psychoactive drugs alter the standard functions of the 
brain (Spinella, 2005; Kihlstrom, 2017). In addition to the point above, how this relates to 
creativity will reveal itself as a more substantial point of focus, rather than maintaining 
the antiquated idea that psychedelics are taboo and should remain so. I will heavily focus 
on lysergic acid diethylamide (LSD), but I will discuss methylenedioxymethamphetamine 
(MDMA), tetrahydrocannabinol (marijuana or cannabis), and psilocybin (magic 
mushrooms), trimethoxyphenethylamine (peyote or mescaline), dimethyltryptamine 
(DMT), and ayahuasca. 
The history of psychedelics goes back to ancient rituals as far back as 3,700 B.C. 
Typically, psychedelics were taken for religious and ritual purposes; however, there is 
some evidence that suggests that these substances enhanced the creativity of the primitive 
man and assisted with the evolution of consciousness, and often these substances are 
referred to as “plants of the gods” (Merlin, 2003). Two forms of evidence have withstood 
time; the primary source is artefactual, and the secondary is paleoethnobotanical which 
heavily relies on radiocarbon dating for accuracy (Merlin, 2003). However, researchers 
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admit there has been some difficulty agreeing upon exact taxa of certain species of plants, 
but this does not cause a major breakdown in the historical background. The artefactual 
evidence is subject to a certain amount of conjecture or interpretation — the purpose of a 
vessel —  whereas paleobotanical evidence is quite a bit more empirical. There is some 
speculation allowed, as it pertains to the role of the plant—if it were ingested in large 
amounts, small doses, etc. — and it would be prudent to understand the plants within the 
context of their historical standing (Merlin, 2003).  
Some of the earliest evidence of psychedelic use dates back to Mesopotamian 
civilization, which spans roughly between 2,000-1,000 B.C.E.; a combination of the drug 
ephedra mixed with marijuana was found in a vessel at a temple shrine near Iran (Merlin, 
2003). This is not the first time, to date, that marijuana was found. In fact, the first 
evidence dates back to 10,000 B.P. in Taiwan, sourced as a main crop in China. Later, 
roughly 1,400 years ago, marijuana appeared in Japan by way of Chinese trading for 
printmaking, clothing production, and for ritual purposes (Hunter, 1978). The first 
ethnographic evidence of recreational use for cannabis dates to 446 B.C. (Merlin, 2003). 
The Chinese were not the only ones to take note of the many uses of marijuana; evidence 
from the Bronze and Iron Age supports that Scandinavian countries, as well as the 
Middle East, were procuring cannabis during antiquity for countless purposes such as 
clothing, rope, and other practical purposes such as medicinal (Merlin, 2003).  
Fast-forward to the 1950’s, a young Timothy Leary and Richard Alpert started the 
Harvard Psilocybin Project which sought to administer psilocybin to volunteers to study 
the effect on consciousness (Hall, 2018). At the time, LSD and psilocybin were both legal 
substances. Unfortunately, their unorthodox methods were a cause for concern to their 
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peers — Leary and Alpert did not have any protocol for participant selection, and poorly 
controlled conditions (Hall, 2018). After providing psilocybin to an undergraduate 
student at Harvard, Leary was terminated and caused the project to end (Hall, 2018). 
Before the negative attention that Leary and Alpert received, LSD was legal; however, 
1966 marks the beginning of the end for psychedelics. Under the Controlled Substances 
Act (CSA) substances were placed in one of five categories based on their dependence 
liability, safety, and potential for abuse. Psychedelics were placed under schedule I 
substances which indicated that there is no currently accepted medical use and high 
potential for abuse, rendering psychedelics illegal (Controlled substances act, 2018). In 
2018 psychedelics are still illegal in some states, despite some states approving medicinal 
marijuana, and even allowing recreational use. Nine states have legalized recreational use 
of marijuana, while twenty-nine states allow medicinal use, and some limit how the 
substance may be used (i.e., oils but not allowing individuals to smoke it) (Robinson, 
Berke & Gould, 2018).  
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The Neuroscience of Psychedelics and their Relationship to  
Creativity 
 
Typically, psychedelics fall into one of five categories: lysergamides, tryptamines, 
or phenethylamines, empathogens, or cannabinoids: 
Dr. David Nichols, of the Department of Medicinal Chemistry and Molecular 
Pharmacology at Purdue University, claims that LSD-25 is the most well-known of the 
lysergamides, and one that was almost entirely overlooked. Thankfully, Albert Hofmann, 
the man who discovered LSD, took a second look at the structure of the molecule; the 
shorthand acronym comes from the original German word: Lyserg-Säure-Diäthylamid 
(Nichols, 2001; Kihlstrom, 2017). Hofmann discovered that LSD was a very special 
molecule because it produced psychoactive effects unlike other lysergic acid molecules, 
which was accomplished by pairing specific reagents — the pairing of nitrogen and ethyl 
(Nichols, 2001). LSD blocks the neurotransmitter serotonin in the brain (Spiegel et al., 
1996). A similar molecule to LSD is ergot, which is known to share psychoactive effects 
(Kihlstrom, 2017; Huxley, 2013). 
Tryptamines are alkaloids (another way of saying compound) responsible for the 
transmission of chemical messages in the brain. Drugs like psilocybin, Ayahuasca, and 
DMT are tryptamines (Spiegel et al., 1996; Kihlstrom, 2017). These compounds produce 
noticeable changes in sensory perception, shifts in mood, and altered states of thinking.  
  Phenethylamines act as central nervous system stimulants which increase 
alertness, psychical activity, euphoric feelings, and attention (Kihlstrom, 2017; Sabelli et 
al., 1976). Mescaline is one of the phenethylamines, which naturally occurs in the peyote 
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and San Pedro cacti (Bruhn, et al. 2008; Kihlstrom, 2017). Adrenochrome, a byproduct of 
adrenalin, can produce similar effects as mescaline (Huxley, 2013) 
Ibogoids, like ibogaine, are used to treat severe opiate addiction. Ibogaine comes 
from the iboga plant native to the Gabon rainforest and stimulates the serotonin receptor 
(Cavendish, 2005). However, in large doses ibogaine causes hallucinations while 
providing long-term effects on the user. The experience is reported to discourage the 
desire to return to drugs like cocaine, heroin, and even nicotine (Cavendish, 2005; 
Spiegel et al., 1996). However, ibogaine is not used in the medical field because of the 
potential dangers such as intense hallucinations, increased heart rate, sweating, and 
nausea, among other side effects (Cavendish, 2005). The University of Sao Paulo is 
currently conducting a trial for the treatment of alcoholism using Ibogaine, which is set to 
begin the next phase in March of 2018 (Dos Santos, 2017).   
Empathogens are chemicals like MDMA or ecstasy that are typically made 
synthetically (Spiegel, Markstein, & Baumann, 1996). However, some evidence suggests 
that ecstasy may naturally occur in the peyote cacti according to Bruhn, Ei-Seedi, 
Stephanson, Beck, and Shulgin (2008). Empathogens are named such because they 
inspire feelings of warmth and empathy when two individuals are under the influence; 
however, they are very neurotoxic to serotonin neurons (Spiegel et al., 1996).  
Cannabinoids are a culmination of over 400 chemicals found within the cannabis 
plant; however, delta-9-tetrahydrocannabinol (THC) is the most potent. Typically 
cannabinoids are not referenced as a psychedelic, however, that is an error in 
understanding: not all cannabinoids are psychoactive, and the potency varies; hashish, or 
dried resin, has the highest concentrate of THC and this accounts for roughly 10-20%, 
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while ganja and sinsemilla, which are from the buds of the plants, average 5-8%, and 
lastly marijuana features the lowest levels of THC, around 2-5% (Spiegel et al., 1996). 
THC is unique as it features a receptor in the brain called anandamide, which is also the 
receptor that induces overeating (Spiegel et al., 1996; (Cavendish, 2005; Williams & 
Kirkham, 1999). The oral version of THC, dronabinol, also falls into this category.     
As one of the most difficult cognitive functions to measure or quantify, creativity 
earns its section of dedication. To understand creativity, one must define terms of this 
paper; the term creativity will be utilized throughout this section as a mode of thought or 
thought process by which some individuals attempt to solve problems, express self, or 
respond to outside stimuli in a novel or unique way. So, what does this mean? Since the 
dawn, of time humans have strived to achieve greatness in all capacities of self-
expression or applied creativity; achievements in literature or writing, mathematics, 
architecture (which, in its own respect, is a hybrid discipline of perfection in mathematics 
and practical/functional design, or fine art), visual arts and design, modes of thought and 
methods of thinking or different ways in which one may express how they experience the 
world, which to most is considered philosophy and often a laughable point to those 
outside the liberal studies, despite however novel or vital to critical thinking they are; the 
very critical thinking that is vital to the everyday problem-solving required of the 
modern-day human. 
Neuroscientists have long been dubious of attempts to measure creativity; 
however, Alice W. Flaherty presents the three-factor anatomical model of human idea 
generation and creative drive in a 2005 article published in the Journal of Comparative 
Neurology. The article denotes that the new model of creative thinking, the three-factor 
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anatomical model, differs from the hemispheric model by attributing that the connections 
between the frontal lobes and the temporal lobes are critical in the creative process rather 
than those, previously thought, between the left and right hemispheres (Flaherty, 2005). 
Additionally, the limbic system, which is primarily responsible for emotions, motivation, 
memories, and learning, is a secondary — albeit important — factor involved in the 
creative process (Flaherty, 2005). Furthermore, motivation holds an essential place in 
creative, novel thinking. Flaherty asks her reader if the temporal lobe is a source of 
suppression for creativity, as patients with conditions known to disrupt temporal lobe 
function, like epilepsy, experience creative bursts when changes occur to the temporal 
lobe —  increased levels of dopamine. Later Flaherty speculates that it may be that highly 
intelligent individuals can find patterns amidst a sensory dump of information overload 
that otherwise escapes understanding. Although, Flaherty reveals that too much dopamine 
blurs the line of understanding and borders on psychosis.  
While the concerns are evident, dopamine enforces reward-seeking behavior, 
particularly novelty-seeking, and may play a rather significant role in the creative 
process. Moreover, while too much activity in the temporal lobe can lead to a myriad of 
issues, like psychosis, it would be safe to assume too little would cause the opposite; 
however, this is not the case. Interestingly, the concept of being blocked — lacking in 
creative fluidity — is not associated with the temporal lobe but rather with the frontal 
lobe (Flaherty, 2005). Creativity does not describe a single process in the brain, but it is 
rather an ability that is facilitated by the temporal lobes, frontal lobes, and the limbic 
system (Sessa, 2008).  
14 
 
 
Heilman, Nadeau, and Beversdorf (2003) and Sessa (2008) believe that a few 
factors are involved in creativity; first, the communication of different areas of the brain, 
diminished levels of a specific neurotransmitter, and extensive specialized knowledge are 
critical to forming novel relationships. Divergent thinking, which is to say that one can 
create novel solutions or alternate thinking to a single problem, is key to creative 
innovation, or the ability to express novelty and understand organized relationships. 
However, creativity requires more than just divergent thinking, as mentioned earlier; 
knowledge and intelligence are necessary, too. For this process to occur, different regions 
of the brain must co-actively communicate — when they otherwise do not (Sessa, 2008; 
Heilman et al., 2003). A unique observation of co-active communication is that 
individuals who lack the creative spark do not experience this mode of thinking with ease 
without psychedelics (Roberts, 2013).  
Talented, or creative, individuals maximize specific areas of the brain while 
engaging in creative thinking — the communication between the frontal lobes and 
particular regions of the temporal and parietal lobes, which are the polymodal and 
supramodal areas. These areas house different forms of knowledge and are crucial to 
creative thinking and bringing together ideas otherwise isolated in the brain (Heilman et 
al., 2003). Moreover, Heilman et al., (2003) argue that diminished levels of the 
neurotransmitter norepinephrine are also directly correlated to the symbiosis required to 
be creative. Because creative thinking relies on seeking novelty, Heilman et al., (2003) 
speculate that the likeliness of individuals who are creative are more inclined to have 
substance abuse problems; as there is some evidence that suggests that exposure to novel 
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stimuli activates the dopamine receptor, which are the same neural substrates that are 
responsible for the reward effects involved in drug and alcohol abuse. 
Stress is associated with high levels of norepinephrine, while relaxed states are 
linked with low levels (Heilman et al., 2003). As mentioned earlier, diminished levels of 
norepinephrine are a key component to creativity, thus indicating that a brain under high 
levels of stress will be less likely to make the necessary connections (i.e., co-actively 
communicate) required to be creative and may also stunt creative thinking and the 
potential mental growth. An additional point Heilman et al., (2003) touch on is the role of 
the neurotransmitter catecholamine, which they believe plays a significant role in 
creativity, but its purpose is still unknown. While individuals like Flaherty may think 
there is a seat of creativity, other researchers like Heilman et al., (2003) may claim that 
there are seats, rather than one, of creativity that requires a range of organization to occur. 
To understand creativity, we must be able to break it down into its most finite pieces. 
Sawyer (2011) claims that cognitive neuroscience focuses on a specific area of the brain 
to provide insight into the creative process. Cognitive neuroscience looks to the 
neocortex for such answers; as it is the location where all higher-level mental functioning 
takes place, such as sensory perception, spatial reasoning, language, and cognition 
(Sawyer, 2011; Lui, Hansen, & Kriegstein, 2011). Functional Magnetic Resonance 
Imaging (fMRI), Electroencephalography (EEG), and Positron Emission Tomography 
(PET) assist with understanding what is occurring in the brain while the creative process 
happens, or while the individual is thinking (Sawyer, 2011). Each test has its strengths 
and weaknesses which is why most researchers use a combination of methods — using 
EEG paired with PET or fMRI with EEG are some options. EEG uses sensors that are 
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attached to the scalp to measure electromagnetic fields produced by neural activity in the 
brain. EEG focuses on brain waves (delta, theta, alpha, beta, and gamma) which are still a 
mystery. Science continues to unpack the purpose of gamma waves; however, some 
researchers believe gamma waves are the source of conscious perception (Sawyer, 2011). 
Brain waves are measured in Hertz that range from .5-20Hz and have been associated 
with different states of consciousness such as sleep states, waking states, and alert states. 
(Sawyer, 2011). The EEG is most sensitive to cortical activity and can detect small 
changes in brain waves when new stimuli are introduced. However, the EEG is limited in 
localization or determining where the neurons are in the brain when causing the change.  
The PET scan works by detecting changes in the cerebral blood flow after a 
radioactive tracer is injected into the bloodstream, which only lasts for a short period, 
around one minute to be exact, then the individual is given a task to complete. The more 
localized radioactivity in the brain, picked up by the PET scan, indicates a higher level of 
activity in that particular area of the brain — which is telling us this is where the 
cognitive functions for a given task are taking place. The PET scan provides a 3D image 
of the brain activity within the one-minute span of time. In comparison to the EEG, the 
PET requires a bit more time, around 40 seconds more, to measure increased brain 
activity (Sawyer, 2011; Raichle, 2009).  
In 1991 fMRI emerged to take the lead in neuroimaging (Raichle, 2009; Sawyer, 
2011). fMRI uses a magnetic field to detect oxygenation in the blood. The spatial 
resolution for fMRI is much higher in contrast to the PET scan. Additionally, fMRI does 
not require a radioactive chemical to be injected into the individual and is capable of 
capturing an image of the brain every two seconds, which is on par with the speed of the 
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EEG, while including the high special recognition like that of the PET (Sawyer, 2011). 
Despite the advantages, the drawbacks of the fMRI are the scale of imaging—fMRI is 
limited in the space it can capture by a few millimeters, which leaves a significant portion 
of the brain in the dark. Were activity to occur in other areas of the brain simultaneously, 
only the area focused on would provide any data as a result. For the reasons outlined 
above, this is precisely why cognitive neuroscientists maximize all options available by 
using mixed methods for collecting data. Other tests are static and limit result 
capabilities. 
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Artists Under the Influence 
 
Throughout history, some individuals have found creative inspiration while under 
the influence of psychedelics. In some circumstances the artist deems it a necessary step 
to take a substance due to stress, depression, or issues with focus, or just plain curiosity. 
Whatever the reason, the outcome is impressive. Although some individuals simply 
appreciate the art that is created by another artist, their love for an obscure genre is vital. 
Some artists maintain that they are not able to create while under the influence but have a 
follow-up process immediately after the psychedelic experience, while other artists 
engage in the creative process while under the influence. Each case is situational and 
Fig. 1: McCloud, M. (2016). Beavis and Butthead  
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dependent on the ingested compound. This section will explore art appreciation, artists, 
and art movements in conjunction with psychedelics.  
Mark McCloud  
 
Mark McCloud is not what one might call a fine artist. However, he is an art 
appreciator who has turned LSD blotters into a collectible and coveted art form (Rhodes, 
2017). The blotter is created by the chemist who synthesizes the LSD, or by the dealer 
who purchases the LSD from the chemist. Once the image is printed on the absorbent 
cardstock either a single dose of LSD is dropped on one square at a time, or the entire 
sheet of paper in soaked in an LSD bath. Once the paper has absorbed the LSD, a single 
dose may be easily pulled away by the perforated edge, then ingested (Fig. 3 below 
Fig. 2: McCloud, M. (2016). Four Eyes 
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features 50 doses; two five by five sheets). Over some decades, McCloud has been 
collecting a wide range of blotters (since the early 70’s) – inspired by a near-death 
experience (NDE) while tripping on LSD; McCloud fell out of a window and was 
“saved” by his NDE (Rhodes, 2017). Each blotter is unique and serves as a staple image 
Fig. 3: McCloud, M. (2016, February 16). Escher 
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that was, in a sense, a calling card so the individuals ingesting the LSD would know 
precisely who synthesized their LSD and where to find it (Rhodes, 2017). McCloud’s San 
Francisco home has become a mausoleum for inactive blotter tabs, over 33,000, in fact 
(Rhodes, 2017; Morgans, 2014; McCloud, 2016). Some are original works, unclaimed by 
their creator (see Fig. 2 above), while others are replicas of works by famous artists like 
M.C. Escher (see Fig. 3 above). Despite the fact that McCloud is not the artist of these 
tabs, he drew attention to the unnoticed. Beyond that, he made the unlikely LSD blotter a 
coveted art form and brought the uniqueness of the cardstock artwork to the foreground 
of people’s minds, which displays the creativity on the part of each dealer or chemist – 
whoever is responsible for these unique tokens. 
 
Fig. 4: Saunders, B. (2008). [Sketchbooks] 
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Bryan Lewis Saunders 
From art appreciators to creators. Some individuals claim they are under the 
influence of a substance or have been while creating art. One artist, in particular, Bryan 
Lewis Saunders, has attested to taking over 60 different drugs and creating more than 
8,000 self-portraits under the influence (Marks, 2016; Watercutter, 2012). The creative 
Fig. 5: Saunders, B. (2008). (Shitty) LSD 
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process for Saunders involves taking one substance at a time; however, in some 
circumstances, a cocktail is ingested, then the artist creates a self-portrait. Saunders has 
been creating self-portraits every day for the last 27 years. These works of art are featured 
in hundreds of sketchbooks housed in his apartment (see Fig. 4 above), and he claims that 
his creative process allows him to have a deeper understanding of self, a sense that he 
Fig. 6: Saunders, B. (2008). DMT 
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believes is a new sensory organ or an extra level of perception that had previously 
escaped understanding (Marks, 2016). Featured are three self-portraits created by the 
artist: the LSD (see Fig. 5) self-portrait, then DMT (see Fig. 6 above), and finally 
marijuana (see Fig. 7 below). The LSD and DMT self-portraits provide an organic line 
structure, while the marijuana portrait is hyper-focused and very linear — note the stanch 
Fig. 7: Saunders, B. (2008). Marijuana  
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contrasted background which features the black and white lines in the background, with a 
centrally focused form in the center foreground of the drawing. Both DMT and LSD 
portraits provide the concept of oneness or melding; the pieces appear to be alive, yet also 
in tune with perceptual norms of spatial understanding—we can tell that we are looking 
at a form of some kind. Not all concept of form is lost, despite being under the influence 
of drugs.  
Saunders further attributes his art and creativity to that of experiencing the 
novelty of life through his CNS (Saunders, 2008), which touches on what Flaherty (2005) 
believes the creative mind is looking for; the sole purpose of pinging the dopamine 
receptor in the brain, something that offers the creative individual the likelier potential of 
abusing drugs, as mentioned earlier. However, there is something to be said for the level 
of intelligence an individual has in conjunction with drug use. Kanazawa (2010) claims 
that the National Child Development Study shows that individuals with higher levels of 
intelligence, and often referred to in childhood as very bright, are more likely to 
experiment with drugs in their time, whereas those with lower levels of intelligence are 
not. The study explored many drugs, and was not limited to psychedelics, and only 
included individuals living in the United Kingdom. However, the study revealed that 
religion, religiosity, personal education and the education of the parents all play a crucial 
role in what motivates one to seek novelty. Novelty-seeking behavior has long stood as 
an evolutionary pillar to continue the species, and some scholars believe that this 
behavior influenced the evolution of consciousness, by inspiring individuals to take 
psychedelics in the first place; something that MacKenna (1993) referred to as the Stoned 
Ape Theory. Moreover, because our society often connects being highly intelligent with 
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the most positive of life outcomes, there’s something to be said for moderate drug use, on 
an evolutionary standpoint, concerning creative thinking (Kanazawa, 2010). 
Aldous Huxley 
Huxley is the author of Brave New World. Aside from Huxley’s lengthy resume, 
he was an avid user of LSD; however, in an interview for The Paris Review, Huxley was 
asked whether he believed that LSD had an impact on the creative process, to which he 
replied;  
I do not think there is any generalization one can make on this. Experience has 
shown that there's an enormous variation in the way people respond to lysergic 
acid. Some people probably could get direct aesthetic inspiration for painting or 
poetry out of it. Others I do not think could. For most people, it is an extremely 
significant experience, and I suppose in an indirect way it could help the creative 
process. However, I do not think one can sit down and say, ‘I want to write a 
magnificent poem, and so I am going to take lysergic acid [diethylamide].’ I do 
not think it is by any means certain that you would get the result you wanted — 
you might get almost any result (Horowitz & Palmer, 1960). 
Huxley goes on to say that the experience that is brought on by LSD is unlike any other, 
one that transcends words or understanding, and without actually living through the 
experience, one that is unimaginable. Of course, LSD offered loci of creativity for 
Huxley, just not in the typical sense. He reports that he was not inspired to write during 
the experience but only after it was over when the unique perspective becomes available 
to the writer (Horowitz & Palmer, 1960). Through this unique worldview, Huxley 
believed that he was able to experience the kind of world that Van Gogh and other 
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creative geniuses lived in (Horowitz & Palmer, 1960; Fraser & Wickes, 2017). Huxley 
wrote about his experience with mescaline in his book, Doors of Perception. In his 
writing, he argues that it is a salutary gift to see ourselves as others see us. It is 
psychedelics that assist changing the ordinary modes of consciousness, and it is our duty 
to self to explore the internal universe (Huxley, 2013).  
Marshall (2012) writes that Aldous Huxley, facing death, asked to take one last 
trip on LSD before he passed away. In a heartwarming interview, his wife Laura 
recounted his final moments as peaceful and calm as he departed earth on an LSD trip. 
Laura stated that Aldous had a beautiful expression on his face as he died with 100 
micrograms of LSD in his system. Huxley’s doctors and nurses stood by in amazement 
while they witnessed his departure; awestruck, as he gently went off which was not an 
ordinary occurrence, as he died from laryngeal cancer.  
Hunter S. Thompson 
Hunter S. Thompson, in comparison to the previously mentioned individuals, did not take 
psychedelics in moderation. Thompson was an acclaimed writer and an avid substance 
user. In fact, he would drink several cups of coffee, then snort line after line of cocaine, 
followed by some marijuana (to take off the edge built up by the cocaine), only to snort 
more cocaine, then later dose LSD (Carroll, 2014). Now he was ready to write. 
Thompson would ingest this described cocktail over the course of the day, which 
produced Fear and Loathing in Las Vegas; a work that ought to be classified as 
autobiographical when compared to the first-hand account that Carroll (2014) describes 
in her book, Hunter: The Strange and Savage Life of Hunter S. Thompson. Thompson’s 
odd mixture of substances did produce something he called Gonzo journalism which was 
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a collaborative effort with the illustrator Ralph Steadman (Steadman, 2014; ). Gonzo 
journalists write from the first-person narrative and include the use of satire and social  
criticism (Carroll, 2014). 
 
 
 
 
Fig. 8: Steadman, R. (2018). Vintage Dr. Gonzo  
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Ralph Steadman 
An artist whose works reflect the chaotic nature of Thompsons’s life is Ralph 
Steadman. Steadman attributes that an LSD experience in 1970 with Thompson sparked 
his illustrating career (Steadman, 2014). In an exchange, after the second-time meeting, 
Steadman asked Thompson if he had anything for sea sickness, and then Thompson gave 
him a dose of LSD. Steadman, completely unaware that he had taken LSD, started being 
creative with spray paint and the rest is history (Steadman, 2014). Although this was the 
only time Steadman took LSD in his life, it had a life-long impact on the artist and his 
work (Steadman, 2014). Steadman brought Fear and Loathing in Las Vegas to life with a 
series of sinister looking illustrations (see Fig. 8, 9, & 10). His style is an expression of  
Fig. 9: Steadman, R. (2018). Gonzo Guilt  
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his emotions, unfiltered and natural but some individuals have suggested that 
Fig. 10: Steadman, R. (2018). Fear and Loathing in Las Vegas 
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Steadman to be a deeply troubled person because of the caustic style of his artwork; 
however, he claims that he gets it all out on paper (Steadman, 2014). 
Psychedelic Art & Wes Wilson 
A counterculture arose during the 1960’s that offered a new type of art inspired by 
psychedelics. Psychedelic art has been described as anything that breaks down 
Fig. 11: Wilson, W. (1966). BG-8 
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conventional ideas of art, experiments with or toys with different concepts and 
perceptions of reality or describes an obscure view of the world; transcendent art (Rivers, 
2013; Krippner, 2016). The works created by psychedelic artists push the limits of the 
optical or visionary regardless of whether or not the creator was under the influence 
before or during their creation (Rivers, 2013). Although psychedelic art has been coined 
as a bridge between modern and contemporary art by some scholars, very little attention  
has been paid to this style, and typically it is not recognized or mentioned in most 
art textbooks (Rivers, 2013). We see it everywhere and do not even know it. An 
overlooked yet well-known artist, Wes Wilson, dedicated his life to creating psychedelic 
poster art (see Fig. 11 & 12), made popular during the 1960’s by the famous promoter, 
Bill Graham (Popeson, 2014; Brignall, 2015). However, there’s no evidence that Wes 
Wilson created these works while under the influence. The artist attributed credit to the 
Art Nouveau movement for inspiration, which was short-lived and popularized around 
the 1850’s, and quickly morphed into the Art Deco movement around the 1910’s (Marien 
& Fleming, 2005). One of the founding fathers of the Art Nouveau movement was Henri 
de Toulouse-Lautrec, an avid psychedelic user (Wilson, 2011; Marien & Fleming, 2005). 
One might speculate that the influence of psychedelics reaches beyond the user to 
influence style, culture, and individuals outside of the experience. This point should be 
considered, given that someone like Wes Wilson — who has not claimed psychedelics as 
a source of influence — drew inspiration from styles formatted with psychedelic 
undertones.  
The limitations for psychedelic art stem from an unclear understanding of stylistic 
expectations; psychedelic artists created whatever immerged from their experience, and 
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they lacked a cohesive manifesto that would group their pieces in an identifiable way. For 
Fig. 12: Wilson, W. (1967). BG-48 
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example, when viewing Impressionist works of art, it is understood that the viewer is  
looking at an Impressionist work, as the art and artist creating the work are following a 
framework for the stylistic expectations (Marien & Fleming, 2005). Typically, we know 
what we are looking at, and where it fits in the art world because it fulfills major 
expectations of the Impressionist style, which makes it easy to classify (Marien & 
Fleming, 2005). Unfortunately, psychedelic art is not necessarily the same, because the 
art aligns with a common experience rather than a common style; a psychedelic 
experience (Krippner, 2016). As a result, the breadth of work is amorphous and difficult 
to pinpoint. If there is a commonality observed in the stylization of psychedelic art, it 
stems from the fundamentals of abstraction and Surrealism, which both play on 
psychoanalytical influences (Krippner, 2016). 
Psychedelic art looked to the two styles and their respective foundations for 
inspiration. Artists like Mark Rothko and Jackson Pollock are two widely known abstract 
artists who claimed their inspiration came from Jungian psychoanalytical theory. 
Psychoanalytic theory suggests that the unconscious mind influences our decisions in 
ways we do not fully understand. How this all effects the creative mind, under the 
influence of psychedelics, is something that continues to reveal itself and remains unclear 
(Browron, 1999; Cernuschi, 1992; Jabr, 2013). Some scholars avoid claiming that 
psychedelic art was a movement at all for these reasons, which is why they rather regard 
it as an “amorphous influence rather than a cogent style” (Rivers, 2013). 
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Current Research on Psychedelics 
A renaissance is currently underway, a new-found interest in psychedelic research 
has been happening right below the surface. The Multidisciplinary Association for 
Psychedelic Studies (MAPS) is a non-profit research and educational organization that 
has been funding psychedelic research since 1986 (O'Neill, 2018). Executive Director 
Rick Doblin, Ph.D. spearheads the effort. In 1972, when he was eighteen years old, 
Doblin dropped out of college. Doblin continued taking LSD during this time and 
believes that he was “educating the mind” by taking LSD as a youth; it started making 
him experience emotions he was not familiar with and confronting new ideas about life 
and reality. Furthermore, Doblin explains that he felt grounded by his experiences with 
LSD and this sense of the world changed into “non-ordinary consciousness” (O'Neill, 
2018).  
After his life-changing experience with psychedelics, Doblin decided that he 
would dedicate his life to research in psychedelic therapy—so that one day he could help 
those who needed the very therapy that he benefited from (O'Neill, 2018). Later, Doblin 
earns a Ph.D. in Public Policy from Harvard’s Kennedy School of Government, which 
serves as an important foundation for MAPS and its future success. Notable supporters 
like Dr. Richard Rockefeller, and his cousin, Senator Jay Rockefeller, assisted Doblin and 
MAPS through the political red tape. For over twenty years Doblin (and MAPS) has been 
working with the Department of Defense on treatments for veterans with severe PTSD; 
therapies with MDMA, specifically; however, MAPS dedicates its resources to a range of 
trials with different psychedelics, not just MDMA (O'Neill, 2018). With the help of the 
Rockefeller’s, Doblin and MAPS have made great progress in psychedelic research with 
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the cooperation of the Department of Veteran Affairs and the Food and Drug 
Administration (FDA). The FDA, since 1966, blocked psychedelic research but in the 
early 1990’s things started to change (Hall, 2018). The FDA allied with science, rejecting 
political agenda (O'Neill,  2018).  
MAPS has long stood as a pillar in research in psychedelics and currently has 
several trials underway: MADMA-assisted psychotherapy, which looks into whether or 
not MDMA assisted therapy can assist with emotional damage sustained by sexual 
assault, war, violent crimes and other trauma (O'Neill, 2018), medical marijuana and 
PTSD, which offers veterans of war marijuana to treat PTSD, along with LSD-assisted 
psychotherapy, ibogaine-assisted therapy, and ayahuasca-assisted therapy are additional 
psychedelics that are currently underway (Thomas, 2013). 
Ross et al. (2016) conducted a randomized, double-blind, controlled, crossover 
study with 29 terminally ill cancer patients at New York University’s Langone’s 
Perlmutter Cancer Center. Each patient received either a placebo that causes rapid heart 
rate (250 mg of niacin) or .3 mg of synthesized psilocybin. Data were collected over a 5-
year span from participants. The purpose of the study was to learn what effect psilocybin 
might have on the anxiety and depression in advanced-stage cancer patients (stages III 
and IV). More than two-thirds of the participants were treated with antidepressants 
without success. Follow-ups with the patients regarding cancer-related existential 
distress, which includes hopelessness, and attitudes and affects associated with death, 
revealed the findings were substantial and long-lasting (Ross et al., 2016). Post-dosing 
patients experienced a reduction in anxiety and depression immediately after dosing 
through the seven-week mark, and even at the six-and-a-half-month follow-up (Ross et 
37 
 
 
al., 2016). Furthermore, anxiety and attitudes toward death improved in the long term 
(six-and-a-half months or more). The psilocybin experience was reported as highly 
meaningful, spiritual, and left positive cognitive and behavioral changes that lasted weeks 
to months for the participants (Ross et al., 2016).  Ross et al. (2016) reveal that more 
research needs to be conducted on a wider range of participants; however, what was 
collected shows the positive effects of psilocybin; spanning as long as eight months in 
this particular trial and only after a single dose — overall mental well-being was reported 
as improved. 
  However, this is not the only study to use psychedelics for psychiatric treatment 
on the terminally ill. Grob et al. (2011) conducted a within-subject, double-blind, 
placebo-controlled study with 12 advanced-stage cancer patients which found that 
patients sustained improved attitudes and decreased anxiety after taking .2 mg doses of 
psilocybin in two sessions which were separated by several weeks. The Beck Depression 
Inventory (BDI) was used as a method to measure the scale of depression pre and post 
dosing; scores dropped almost 30% after the first session, maintaining up to the six-
month follow-up (Grob et al., 2011). In another study conducted by Lyons and Carhart-
Harris (2018) psilocybin was administered in much higher doses than previously 
mentioned; first 10 mg, as a safety, then 25 mg. The dosing sessions were separated by 
one week. Findings revealed longer lasting effects on decreased levels of authoritarianism 
and depression for seven to twelve months following two doses and increased levels of 
interconnectedness with nature for seven to twelve months after dosing (Lyons & 
Carhart-Harris, 2018).   
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 Limited research on medical marijuana has been published despite the increased 
popularity in the United States over the last two decades (Birdsall, M, Birdsall, T & 
Tims, 2016). Currently, seven clinical trials are in place with some mixed findings 
(Interventional Studies, 2018).  Because medical marijuana has the potential for 
medicinal applications more research is required; however, some researchers suggest that 
vaporizing marijuana as a pain management solution is a viable alternative to opiates. By 
vaporizing the marijuana, the patient reduces the number of hazardous carcinogens 
(Birdsall et al., 2016; Weintraub, 2018). Some research suggests that cannabidiol (CBD), 
which is extracted from the same plant but does not produce psychoactive effects, may be 
beneficial for pain management and the treatment of cancer (Johnson, 2017; Mcallister, 
Soroceanu & Desprez, 2015). CBD is unique as it influences the body to utilize its own 
CB1 and CB2 receptors in the brain — the body naturally produces cannabinoids 
(Johnson, 2017). CB1 is responsible for coordination, pain, emotions, and appetite, while 
CB2 is responsible for receptors relating to the immune system, specifically 
inflammation, and pain (Johnson, 2017). The first evidence that CBD is in part 
responsible for antitumor activity was in a study conducted by Singer et al., (2015).  
Roughly twenty studies conducted between 2000 - 2015 revealed that cancer cell growth 
decreased, and malignancy of tumors decreased in humans and rats over a range of 
cancer types (Mcallister, Soroceanu & Desprez, 2015; Singer et al., 2015).  
Previously noted, ayahuasca is a combined compound composed of Banisteriopsis 
caapi and the leaves of Psychotria virdis; DMT and harmala alkaloids (Bouso et al., 
2015). Very little clinical research on ayahuasca exists. In a recent study conducted by 
Bouso et al., (2015) long-term use of psychedelic drugs is associated with changes in 
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brain structure and alters personality. The study used MRI images of 22 regular users of 
ayahuasca. Participants were limited to members of the Santo Daime church located in 
Barcelona, Spain.  The study’s inclusion criteria required that participants have taken 
ayahuasca at least fifty times in the previous two years, no history of psychiatric or 
neurological disorders, limited lifetime drug use outside of ayahuasca, and no drug use 
for two weeks before the study (Bouso et al., 2015). Several tests were issued to the 
participants, including but not limited to the Temperament and Character Inventory-
Revised (TCI-R), A psychopathological assessment using the Symptom Check-List-90-
Revised (SCL-90-R) questionnaire, which measures anxiety depression and 
psychoticism, and three neuropsychological tests in order to create a baseline for the 
participants (Bouso et al., 2015). The data reveal that long-term use alters attitudes and 
interests in participants, such that they become more cognitively flexible (open-minded) 
and less materialistic, gaining mystic-like feelings, or oneness (Bouso et al., 2015). In 
fact, ayahuasca users displayed higher than average levels of self-transcendence, a feeling 
linked to religiousness and spirituality, and thinning of the cortical thickness (CT), 
according to Bouso et al. (2015). 
Microdosing is the long-term (or short-term, as it is in complete control of the 
user) use of psychedelics like LSD & psilocybin, self-administered as a way to enhance 
consciousness; LSD & psilocybin are said to heighten awareness, and spiritual affect, and 
to increase focus, boost creativity, and stabilize mood (Johnstad, 2018; Oberhaus, 2017; 
Doblin, 2016). Low doses range anywhere from .5 mg up to 10 mg for LSD, and 
anywhere from .2g to .5g for psilocybin, while some experienced psychedelic users self-
report higher doses in the 10 – 20 mg range, which appears to be a rather blurred line, and 
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indicates that dosing can be person-by-person basis (Johnstad, 2018; Doblin, 2017). The 
purpose of controlling the dosing is to gain the positive mental insights of the 
psychedelics without actually experiencing the psychoactive effects. However, one 
indisputable point is the span between microdoses, which seems to be key, as some users 
report negative effects if taken too close together or in consecutive days without rest 
(Johnstad, 2018). A recommended dosing schedule should be taken in the morning every 
fourth day, and it is best to start with less and feel out one’s system. The idea is to 
improve and enhance overall cognition, rather than experience a drug high. 
  Over the past few decades, microdosing has become increasingly popular in 
Silicon Valley and more recently has been spreading to other cities as the promise for 
better focus and creativity, which offers a much-needed edge in big business (Solon, 
2017; Sahakian, D'Angelo, & Savulich, 2018). However, there are some issues with self-
administering LSD, and psilocybin; there is a very fine line between a microdose and a 
minidose, which houses more powerful psychoactive effects on the individual. So, 
understanding the precise amount of the drug that is ingested is a key component to the 
success of the micro versus the mini (Johnstad, 2018). Because there are no clinical 
studies on micro-dosing currently available, the jury is still out on this topic; however, 
Jim Fadiman has been microdoing for several years as well as Albert Hofmann (Kabil, 
2016; Fadiman, 2018). Hofmann microdosed for at least the last twenty years of his life, 
and he lived to the age of 102 (Hall, 2016). 
In some circumstances, users of psychedelics, outside the medical application like 
clinical research, encounter a difficult trip. A difficult trip is one that causes the user 
panic, anxiety, or great fear. Often this leads to erratic behavior and thought patterns, 
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which can lead to mental destruction — a mental break. The Zendo Project, which is a 
side project of MAPS, offers peer support to individuals who are overwhelmed and 
uncomfortable while in a non-ordinary state of consciousness (O'Neill, 2018). Zendo’s 
goal is to reduce the number of harmful experiences that may arise – mental breaks, 
arrests, etc.— within the community. As a preventative measure, Zendo psychologists 
and psychiatrist deploy to festivals all over the world to reduce the number of harmful 
psychedelic experiences (O'Neill, 2018).  
The dangers of tryptamine derivatives, synthetically produced, like alpha-
methyltryptamine (AMT), 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) and 5-
methoxy-N, N-diisopropyltryptamine (5-MeO-DIPT), are clear according to Margarida 
Araujo (2015). Now, they are widely available in headshops, which are locations that 
tobacco pipes are available, for anyone to purchase. Researcher Margarida Araujo (2015) 
expresses concern for the increased availability of these synthetic tryptamines to the 
public, as the compound has been linked to some deaths.  
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Final Thoughts 
As I reflected on which topic I desired most to write about, I did not hesitate with 
a response which leads me right to psychedelics. I have modestly explored with 
psychedelics over the course of my life and have long-lasting impressions from each 
experience, just like the research above outlines, which is what primarily influenced my 
decision to write about such a taboo topic. Though this section will be rather anecdotal, I 
believe it is an appropriate — albeit liberal — way to end my writing. In the beginning, I 
featured a quote of Einstein’s which I mentioned has inspired me a great deal. I have 
often struggled with providing my true thought for fear of a deeply negative reaction. I 
have experienced a great deal of opposition to obscure topics, which is why I felt it was 
Fig. 13: McCloud, M. (2016). Beavis and Butthead  
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necessary to choose a topic that I felt deeply passionate about—no matter the reaction I 
received. 
My journey with psychedelics began many years ago. Weekdays, I typically 
focused on working and attending school for my undergraduate degree. At the time I was 
working full time and going to school full time, so the weekends were mine; my 
cherished time where I was able to catch up on things around the house. I typically spent 
this time finishing up the homework that I was not able to manage during the busy week 
and other mundane chores that seemed never-ending. One particular Saturday I cleaned 
my modestly sized two-bedroom apartment with my then long-term boyfriend, put up 
lights to set a mood, and prepared the house for a special occasion; this weekend would 
be anything but mundane because I was going to do LSD for the first time. Each time I 
have ingested a psychoactive substance I have done my best to mentally prepare, in all 
capacities, to ensure the most successful and positive experience possible.  
From a small black box, which was ornately adorned with plastic geometric 
shapes on all sides, I grabbed a little plastic zip-lock. Inside the bag were four square-cut 
pieces of paper with little Beavis & Butthead figures appropriately, printed on them (see 
Fig. 13). I placed the paper on my tongue and let it settle. Earlier in the day, I set out 
paint, canvases, drawing paper, and my coveted Prisma-Color markers all because I 
hoped that I might feel inspired to create something — during this time in my life I had 
been experiencing a lull in creativity. I was not sure what to expect despite all of the 
experiences that people, within my circle of friends, shared with me over the years. After 
all, no two people experience LSD the same. A bit of time passed, and as I walked down 
the hallway, I casually looked over and noticed the rope lights, lining the hallway floor, 
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throbbing like they were breathing; like they were alive. At the time I just observed the 
event, a bit captivated by an ordinarily inanimate object, something that typically would 
not attract my attention for more than a fraction of a second, which engaged me for what 
seemed to be an eternity. I walked over and touched the rope lights, knowing I was 
experiencing an LSD-induced hallucination and held the rope between my thumb and 
forefinger as it continued to expand and contract in my hand. My significant other 
distracted my attention away from the breathing light toward the living room, where my 
art supplies waited for me.  
My perception of time altered — my experience seemed very rapid at first, then 
later slowed down into a very distorted sense of reality. My limbs looked like they were 
in a movie, but they were not playing in sync with their surroundings — I did not realize 
then that this was typical of LSD. Nevertheless, I went with it because I knew to expect 
the unexpected with LSD. Everything in my reality started to glitch or skip around a bit, 
especially my arms and hands or the things closest in my depth-of-field. For the first 
time, as I was drawing, I experienced what felt like freedom, or something I believe to be 
beautiful, a oneness with something I was creating, the very familiar oneness that many 
participants from the clinical trials that I have reference refer to. So, in a sense, we share 
this moment.  
The ink coming from my markers felt like it was an extension of me and I began to 
reflect on the years of art I had created up to this point. I longed for its return, as almost 
all of my work-to-date occupied homes outside of my own.  I swelled with emotion as I 
thought of how connected I felt to the things I had given life to. In the years proceeding 
this moment, I had been so incredibility self-critical, I was never able to enjoy the art-
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making processes so profoundly, at least not in the way that I was while under the 
influence of LSD. I have struggled with perfecting everything I attempt to make or do, 
creatively or otherwise, and I continue to satiate for that perfect moment of creation that I 
Fig. 14: Roun, J. (2016). Dematerialize 
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once had under the influence. I have always been able to find fault or err in things that I 
create, and I have never felt satisfied with anything that I have made, outside of my  
experiences with hallucinogens.  
  Just like the artist I have written about I too have created works of art under the 
influence. Outlined below are a few of the pieces I have created over the years while 
Fig. 15: Roun, J. (2016). L’oeil 
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under the influence of different substances, some more recent than others: as I reflect on 
the line quality in pieces above, I cannot help but notice the similarities. If compared to 
Saunder’s pieces they are akin! The precision in line work is parallel, and the LSD pieces 
(see Fig. 20 & 21) feature the same bubbly, free-flowing blob-like forms as Saunder’s 
self-portrait on LSD. Figures 14 - 19 were made while under the influence of marijuana, 
Fig. 20 & 21 while under the influence of LSD, and Fig. 22, 23, and 24 while under the 
influence of cocaine.  
 
   
 
 
 
 
 
 
Fig. 16: Roun, J. (2018). Oculus Videre  
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Fig. 17: Roun, J. (2016) Linear I 
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Fig. 18: Roun, J. (2016) Semper fidelis ad Mortem 
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Fig. 19: Roun, J. (2016) Replica 
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Fig. 20: Roun, J. (2016) Snoopy 
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Fig. 21: Roun, J. (2016) Untitled 
53 
 
 
 
 
 
 
 
 
 
Fig. 22: Roun, J. (2016). Deep blue I 
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Fig. 23: Roun, J. (2016). Deep blue II 
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Fig. 24: Roun, J. (2016). Deep blue III 
 
I 
56 
 
 
My research concludes that there are many benefits and many dangers to taking 
hallucinogens. However, being informed and taking these compounds in moderation 
seems to be key, or at least that is what I believe. It is when excess is embraced, as in the 
Hunter S. Thompson example, that the limit is pushed, and no true psychological gain is 
achieved. There will always exist the possibility of a bad psychedelic experience (trip), as 
nothing in this life is free from risk, but the user should be informed and aware of this 
possibility and take life one trip at a time.  
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